TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Jenving Clinical Trial Services AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
795
|
772
|
832 |
Financial expenses |
0
|
1
![]() |
1 |
Earnings before taxes |
134
|
246
|
205 |
EBITDA |
128
|
229
|
209 |
Total assets |
1,183
|
1,206
|
1,376 |
Current assets |
839
|
1,014
|
1,283 |
Current liabilities |
137
|
43
|
68 |
Equity capital |
965
|
1,090
|
1,134 |
- share capital |
34
|
33
|
36 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
81.6%
|
90.4%
|
82.4% |
Turnover per employee |
795
|
772
|
832 |
Profit as a percentage of turnover |
16.9%
|
31.9%
|
24.6% |
Return on assets (ROA) |
11.3%
|
20.5%
|
15.0% |
Current ratio |
612.4%
|
2358.1%
|
1886.8% |
Return on equity (ROE) |
13.9%
|
22.6%
|
18.1% |
Change turnover |
19
|
7
|
-264 |
Change turnover % |
2%
|
1%
|
-24% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.